FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Stephanie Safgren

Research Profile

Disorders

Concepts & Ideas

Chemicals & Drugs

Procedures

Living Beings

Infants

Co-author Network

Publications

TOP 3
Anne B Warwick; Peter Charles Adamson; Matthew M Ames; Richard Gorlick; Mark Krailo; Suman Malempati; Allen Melemed; Stephanie L Safgren; Susan M Blaney
Phase 2 trial of pemetrexed in children and adolescents with refractory solid tumors: a Children's Oncology Group study.
Matthew P Goetz; Richard Greil; Tanya L Hoskin; Matthew M Ames; Otto Dietze; Martin Filipits; Michael Gnant; Raimund Jakesz; Mary Kuffel; Alois Lang; Felix Offner; Carol A Reynolds; Margaretha Rudas; Stephanie L Safgren; Vera J Suman; Richard M Weinshilboum; James N Ingle
CYP2D6 metabolism and patient outcome in the Austrian Breast and Colorectal Cancer Study Group trial (ABCSG) 8.
Kurt A Jaeckle; Karla V Ballman; Caterina Giannini; Paula J Schomberg; Matthew M Ames; Joel M Reid; Renee M McGovern; Stephanie L Safgren; Evanthia Galanis; Joon H Uhm; Paul D Brown; Julie E Hammack; Robert Arusell; Daniel A Nikcevich; Roscoe F Morton; Donald B Wender; Jan C Buckner
Phase II NCCTG trial of RT + irinotecan and adjuvant BCNU plus irinotecan for newly diagnosed GBM.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Stephanie Safgren (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Anne B Warwick; Peter Charles Adamson; Matthew M Ames; Richard Gorlick; Mark Krailo; Suman Malempati; Allen Melemed; Stephanie L Safgren; Susan M Blaney
Phase 2 trial of pemetrexed in children and adolescents with refractory solid tumors: a Children's Oncology Group study.
Pediatric blood & cancer 2013;60(2):237-41.
2013: Matthew P Goetz; Richard Greil; Tanya L Hoskin; Matthew M Ames; Otto Dietze; Martin Filipits; Michael Gnant; Raimund Jakesz; Mary Kuffel; Alois Lang; Felix Offner; Carol A Reynolds; Margaretha Rudas; Stephanie L Safgren; Vera J Suman; Richard M Weinshilboum; James N Ingle
CYP2D6 metabolism and patient outcome in the Austrian Breast and Colorectal Cancer Study Group trial (ABCSG) 8.
Clinical cancer research : an official journal of the American Association for Cancer Research 2013;19(2):500-7.
2010: Kurt A Jaeckle; Karla V Ballman; Caterina Giannini; Paula J Schomberg; Matthew M Ames; Joel M Reid; Renee M McGovern; Stephanie L Safgren; Evanthia Galanis; Joon H Uhm; Paul D Brown; Julie E Hammack; Robert Arusell; Daniel A Nikcevich; Roscoe F Morton; Donald B Wender; Jan C Buckner
Phase II NCCTG trial of RT + irinotecan and adjuvant BCNU plus irinotecan for newly diagnosed GBM.
Journal of neuro-oncology 2010;99(1):73-80.
2010: Lars M Wagner; John P Perentesis; Joel M Reid; Matthew M Ames; Stephanie L Safgren; Marvin D Nelson; Ashish M Ingle; Susan M Blaney; Peter Charles Adamson
Phase I trial of two schedules of vincristine, oral irinotecan, and temozolomide (VOIT) for children with relapsed or refractory solid tumors: a Children's Oncology Group phase I consortium study.
Pediatric blood & cancer 2010;54(4):538-45.
2010: Mark R Litzow; Prema P Peethambaram; Stephanie L Safgren; Gary L Keeney; Stephen M Ansell; Angela Dispenzieri; Michelle A Elliott; Dennis A Gastineau; Morie A Gertz; David J Inwards; Martha Q Lacy; Ivana N M Micallef; Luis F Porrata; W L Lingle; Lynn C Hartmann; M H Frost; B A Barrette; Harry J Long; Vera J Suman; Joel M Reid; Matthew M Ames; S H Kaufmann
Phase I trial of autologous hematopoietic SCT with escalating doses of topotecan combined with CY and carboplatin in patients with relapsed or persistent ovarian or primary peritoneal carcinoma.
Bone marrow transplantation 2010;45(3):490-7.
2009: Werner Schroth; Matthew P Goetz; Ute Hamann; Peter A Fasching; Marcus Schmidt; Stefan Winter; Peter Fritz; Wolfgang Simon; Vera J Suman; Matthew M Ames; Stephanie L Safgren; Mary J Kuffel; Hans Ulrich Ulmer; Julia Boländer; Reiner Strick; Matthias W Beckmann; Heinz Koelbl; Richard M Weinshilboum; James N Ingle; Michel Eichelbaum; Matthias Schwab; Hiltrud Brauch
Association between CYP2D6 polymorphisms and outcomes among women with early stage breast cancer treated with tamoxifen.
JAMA : the journal of the American Medical Association 2009;302(13):1429-36.
2008: Liang Li; Brooke L Fridley; Krishna Kalari; Gregory Jenkins; Anthony Batzler; Stephanie L Safgren; Michelle A T Hildebrandt; Matthew Ames; Daniel Schaid; Liewei Wang
Gemcitabine and cytosine arabinoside cytotoxicity: association with lymphoblastoid cell expression.
Cancer research 2008;68(17):7050-8.
2008: Marina Gálvez-Peralta; Nga T Dai; David Loegering; Karen Flatten; Stephanie L Safgren; Jill M Wagner; Matthew M Ames; Larry M Karnitz; Scott H Kaufmann
Overcoming S-phase checkpoint-mediated resistance: sequence-dependent synergy of gemcitabine and 7-ethyl-10-hydroxycamptothecin (SN-38) in human carcinoma cell lines.
Molecular pharmacology 2008;74(3):724-35.
2008: Chitta Ranjan Patra; Resham Bhattacharya; Enfeng Wang; Aaron Katarya; Julie S Lau; Shamit Dutta; Michael Muders; Shanfeng Wang; Sarah A Buhrow; Stephanie L Safgren; Michael J Yaszemski; Joel M Reid; Matthew M Ames; Priyabrata Mukherjee; Debabrata Mukhopadhyay
Targeted delivery of gemcitabine to pancreatic adenocarcinoma using cetuximab as a targeting agent.
Cancer research 2008;68(6):1970-8.
2007: Suman Malempati; H Stacy Nicholson; Joel M Reid; Susan M Blaney; Ashish Ingle; Mark Krailo; Linda C Stork; Allen S Melemed; Renee M McGovern; Stephanie L Safgren; Matthew M Ames; Peter Charles Adamson
Phase I trial and pharmacokinetic study of pemetrexed in children with refractory solid tumors: the Children's Oncology Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(12):1505-11.
2007: Brenda J Weigel; Susan M Blaney; Joel M Reid; Stephanie L Safgren; Rochelle Bagatell; John H Kersey; Joseph P Neglia; S Percy Ivy; Ashish Ingle; Luke Whitesell; Richard J Gilbertson; Mark Krailo; Matthew Ames; Peter Charles Adamson
A phase I study of 17-allylaminogeldanamycin in relapsed/refractory pediatric patients with solid tumors: a Children's Oncology Group study.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(6):1789-93.
2007: Matthew P Goetz; Stacey K Knox; Vera J Suman; James M Rae; Stephanie L Safgren; Matthew M Ames; Daniel W Visscher; Carol Reynolds; Fergus J. Couch; Wilma L Lingle; Richard M Weinshilboum; Emily G Barr Fritcher; Andrea M Nibbe; Zeruesenay Desta; Anne Nguyen; David A Flockhart; Edith A Perez; James N Ingle
The impact of cytochrome P450 2D6 metabolism in women receiving adjuvant tamoxifen.
Breast cancer research and treatment 2007;101(1):113-21.
2006: Grzegorz S Nowakowski; Andrea K McCollum; Matthew M Ames; Sumithra J Mandrekar; Joel M Reid; Alex A. Adjei; David O Toft; Stephanie L Safgren; Charles Erlichman
A phase I trial of twice-weekly 17-allylamino-demethoxy-geldanamycin in patients with advanced cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(20 Pt 1):6087-93.
2005: Matthew P Goetz; James M Rae; Vera J Suman; Stephanie L Safgren; Matthew M Ames; Daniel W Visscher; Carol Reynolds; Fergus J. Couch; Wilma L Lingle; David A Flockhart; Zeruesenay Desta; Edith A Perez; James N Ingle
Pharmacogenetics of tamoxifen biotransformation is associated with clinical outcomes of efficacy and hot flashes.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(36):9312-8.
2005: Julian R Molina; Joel M Reid; Charles Erlichman; Jeff A Sloan; Alfred F Furth; Stephanie L Safgren; Chetan Lathia; Steven R Alberts
A phase I and pharmacokinetic study of the selective, non-peptidic inhibitor of matrix metalloproteinase BAY 12-9566 in combination with etoposide and carboplatin.
Anti-cancer drugs 2005;16(9):997-1002.
2005: Scott H Kaufmann; Judith E Karp; Louis Letendre; Timothy J Kottke; Stephanie L Safgren; Jacqueline Greer; Ivana Gojo; Pamela J Atherton; Phyllis A Svingen; David Loegering; Mark R Litzow; Jeff A Sloan; Joel M Reid; Matthew M Ames; Alex A. Adjei; Charles Erlichman
Phase I and pharmacologic study of infusional topotecan and Carboplatin in relapsed and refractory acute leukemia.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(18):6641-9.
2005: Matthew P Goetz; David O Toft; Joel Reid; Matthew Ames; Bridget Stensgard; Stephanie L Safgren; Alex A. Adjei; Jeff Sloan; Pamela J Atherton; Vlad Vasile; Sandra Salazaar; Alex Adjei; Gary A Croghan; Charles Erlichman
Phase I trial of 17-allylamino-17-demethoxygeldanamycin in patients with advanced cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(6):1078-87.
2004: Joel M Reid; Wenchun Qu; Stephanie L Safgren; Matthew M Ames; Mark Krailo; Nita L Seibel; John Frank Kuttesch; John Holcenberg
Phase I trial and pharmacokinetics of gemcitabine in children with advanced solid tumors.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(12):2445-51.
2002: Peter G Steinherz; Nita L Seibel; Matthew M Ames; Vassilios I Avramis; Mark Krailo; Wen Liu; Joel M Reid; Stephanie L Safgren; Gregory H Reaman
Phase I study of gemcitabine (difluorodeoxycytidine) in children with relapsed or refractory leukemia (CCG-0955): a report from the Children's Cancer Group.
Leukemia & lymphoma 2002;43(10):1945-50.
2001: Evanthia C Galanis; Richard M Goldberg; J Reid; Pamela J Atherton; J Sloan; Henry C Pitot; Joseph Rubin; Alex A. Adjei; P Burch; Stephanie L Safgren; T E Witzig; Matthew M Ames; Charles Erlichman
Phase I trial of sequential administration of raltitrexed (Tomudex) and 5-iodo-2'-deoxyuridine (IdUrd).
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2001;12(5):701-7.
2001: Stephanie L Safgren; Joel M Reid; R Rios; Matthew M Ames
Validated high-performance liquid chromatographic assay for simultaneous determination of dacarbazine and the plasma metabolites 5-(3-hydroxymethyl-3-methyl-1-triazeno)imidazole-4-carboxamide and 5-(3-methyl-1-triazeno)imidazole-4-carboxamide.
Journal of chromatography. B, Biomedical sciences and applications 2001;754(1):91-6.
2000: S V Rajkumar; Joel M Reid; P J Novotny; Stephanie L Safgren; B W Scheithauer; P S Johnson; S Nair; Roscoe F Morton; A K Hatfield; James E Krook; Matthew M Ames; Jan C Buckner
A randomized phase II and pharmacokinetic study of dacarbazine in patients with recurrent glioma.
Journal of neuro-oncology 2000;49(3):255-61.